Common Rule
45 C.F.R. Part 46Federal Policy for the Protection of Human Subjects
In force since July 19, 2018
Who it applies to
- Human-subjects research conducted or supported by a Common Rule department or agency
- Research at institutions that have voluntarily extended the policy to all their research through a federalwide assurance
Consumer rights
- Access / know, grantedObtain the personal data held about you, and the categories, sources and purposes behind it.
- Correction, not granted
- Deletion / erasure, not granted
- Portability, not granted
- Opt out of sale / sharing, not granted
- Opt out of targeted advertising, not granted
- Opt out of profiling, not granted
- Limit sensitive data use, not granted
- Human review of automated decisions, not granted
- Non-discrimination, not granted
- Appeal a refusal, grantedHave a denied request reconsidered through a stated appeals process.
- Private right of action, not granted
Obligations
- Consent model
- Opt-in
- Universal opt-out signal
- Not required
- Risk assessments
- Required for higher-risk processing
- Data protection officer
- Not required
- Records of processing
- Not required
- Processor contract
- Not required
- Right to cure
- None: enforcement may follow immediately
- Data broker registration
- Not required
- Minors
- Parental permission plus the child's assent, with the IRB judging the child's capacity to assent.
Breach notification
- To individuals
- No breach-notification duty of its own
- To the regulator
- Unanticipated problems involving risks to subjects are reported to OHRP and the IRB promptly
- What triggers it
- Not applicable as a breach regime; the reportable event is an unanticipated problem or a serious non-compliance finding
Penalties
- Headline
- Suspension or termination of federal funding and of the institution's assurance, rather than a monetary penalty
- Private right of action
- No, enforcement is by the regulator only
- Notes
- TWO SEPARATE PERMISSIONS, AND RESEARCHERS ROUTINELY SECURE ONE. IRB approval under this Part authorises the research; it does not authorise a covered entity to hand over the records. That takes a HIPAA authorization or a waiver under 45 C.F.R. § 164.512(i). Clearing the IRB and assuming the data may now flow is the failure mode the pathway instrument's research lane is built around.
Exemptions
Entities
- Privately funded research at an institution that has not extended the policy, which is reached by the FDA's rules or by nothing at all
Data
- Secondary research on information collected for another purpose, where the identifiers are not accessible to the investigator
- Eight categories of exempt research, including certain benign behavioural interventions and public-benefit programme evaluation
Amendment history
January 21, 2019
Revised Common Rule, general compliance date
Required a concise key-information section at the front of consent forms, allowed broad consent for secondary research use of identifiable data, and mandated single IRB review for cooperative research.
Sources
- PrimaryRegulation45 C.F.R. Part 46, Protection of Human Subjects
- OfficialRegulatorHHS Office for Human Research Protections